Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid (Q35093824)

6 August 2017

Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid (English)

1 reference

6 August 2017

1 reference

1 reference

S L Silverman

1

1 reference

6 August 2017

A Kriegman

2

1 reference

6 August 2017

J Goncalves

3

1 reference

6 August 2017

F Kianifard

4

1 reference

6 August 2017

T Carlson

5

1 reference

6 August 2017

E Leary

6

1 reference

6 August 2017

language of work or name

English

0 references

publication date

30 November 2010

1 reference

Osteoporosis International

6 August 2017

1 reference

6 August 2017

22

1 reference

6 August 2017

8

1 reference

6 August 2017

2337-2345

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-010-1448-2

6 August 2017

0 references

cites work

Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132314

Atorvastatin may have no effect on acute phase reaction in children after intravenous bisphosphonate infusion

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132314

Zoledronic acid and clinical fractures and mortality after hip fracture

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132314

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132314

The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132314

Management of the adverse effects associated with intravenous bisphosphonates

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132314

Bisphosphonates: preclinical review

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132314

Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132314

C-reactive protein: a critical update

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132314

Activation of C-C beta-chemokines in human peripheral blood gammadelta T cells by isopentenyl pyrophosphate and regulation by cytokines.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132314

An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132314

Isopentenyl pyrophosphate, a mycobacterial non-peptidic antigen, triggers delayed and highly sustained signaling in human gamma delta T lymphocytes without inducing eown-modulation of T cell antigen receptor

9 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-010-1448-2

Statins prevent bisphosphonate-induced gamma,delta-T-cell proliferation and activation in vitro.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-010-1448-2

10.1007/S00198-010-1448-2

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference